Survivin apoptosis: An interloper between cell death and cell proliferation in cancer

Laboratory Investigation

Volumn 79, Issue 11, 1999, Pages 1327-1333

  Altieri, Dario C ^a   Marchisio, Carlo ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CHROMOSOME 17; COLORECTAL CANCER; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STOMACH CANCER;

ANIMALS; APOPTOSIS; CELL DEATH; CELL DIVISION; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PROTEINS;

EID: 0032735232     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Adams JM and Cory S (1998). The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326.
2. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, and Altieri DC (1998a). Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-883.
3. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, and Altieri DC (1998b). Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43-49.
4. Altieri DC (1995). Xa receptor EPR-1. FASEB J. 9:860-865.
5. Ambrosini G, Adida C, and Altieri DC (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
6. Ambrosini G, Adida C, Sirugo G, and Altieri DC (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-11182.
7. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, and Casciola-Rosen L (1998). Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis. Immunity 8:451-460.
8. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, and Vogelstein B (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303.
9. Clem RJ and Duckett CS (1997). The iap genes: Unique arbitrators of cell death. Trends Cell Biol 7:337-339.
10. Clem RJ and Miller LK (1994). Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14:5212-5222.
11. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WE, and Reid BJ (1995). A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
12. Deveraux QL and Reed JC (1999). IAP family proteins-suppressors of apoptosis. Genes Dev 13:239-252.
13. Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, and Armstrong RC (1998). Human IAP-like protein regulates programmed cell death downstream of Bcl-XL and cytochrome c. Mol Cell Biol 18:608-615.
14. Elledge SJ (1996). Cell cycle checkpoints: Preventing an identity crisis. Science 274:1664-1672.
15. Evan G and Littlewood T (1998). A matter of life and cell death. Science 281:1317-1322.
16. Field C, Li R, and Oegema K (1999). Cytokinesis in eukaryotes: A mechanistic comparison. Curr Opin Cell Biol 11:68-80.
17. Fraser AG, James C, Evan GI, and Hengartner MO (1999). Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 9:292-301.
18. Green DR and Martin SJ (1995). The killer and the executioner: How apoptosis controls malignancy. Curr Opin lmmunol 7:694-703.
19. Grossman D, McNiff JM, Li F, and Altieri DC (1999). Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121-1126.
20. Grossman D, McNiff JM, Li F, Altieri DC (in press, 1999b). Expression and target of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol.
21. Hauser H-P, Bardroff M, Pyrowolakis G, and Jentsch S (1998). A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J Cell Biol 141:1415-1422.
22. Hirokawa N (1994). Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 6:74-81.
23. Hockenbery D (1995). Defining apoptosis. Am J Pathol 146: 16-19.
24. Jacobson MD, Weil M, and Raff MC (1997). Programmed cell death in animal development. Cell 88:347-354.
25. Joshi HC (1994). Microtubule organizing centers and γ-tubulin. Curr Opin Cell Biol 6:55-62.
26. Kawasaki H, Altieri DC, Lu C-D, Toyoda M, Tenjo T, and Tanigawa N (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074.
27. Khochbin S and Lawrence J (1989). An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate. EMBO J. 8:4107-4114.
28. Kobayashi K, Hatano M, Otaki M, Ogasawara T, and Tokuhisa T (1999). Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 96:1457-1462.
29. Krystal GW, Armstrong B, and Battey JF (1990). N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol Cell Biol 10:4180-4191.
30. LaCasse EC, Baird S, Korneluk RG, and MacKenzie AE (1998). The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247-3259.
31. Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
32. Li F and Altieri DC (in press, 1999a). Transcriptional analysis of human survivin gene expression. Biochem J.
33. Li F and Altieri DC (1999b). The cancer anti-apoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 59:3143-3151.
34. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, and Altieri DC (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
35. Lu C-D, Altieri DC, and Tanigawa N (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812.
36. Lupas A, Van Dyke M, and Stock J (1991). Predicting coiled coils from protein sequences. Science 252:1162-1164.
37. Macleod D, Charlton J, Mullins J, and Bird AP (1994). Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 8:2282-2292.
38. Madaule P, Eda M, Watanabe N, Fujisawa K, Matsuoka T, Bito H, Ishizaki T, and Narumiya S (1998). Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature 394:491-494.
39. McNally FJ (1996). Modulation of microtubule dynamics during the cell cycle. Curr Opin Cell Biol 8:23-29.
40. L and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10:2621-2631.
41. Nigg EA (1998). Polo-like kinases: Positive regulators of cell division from start to finish. Curr Opin Cell Biol 10:776-783.
42. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, and Feuerstein BG (1997). Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
43. Reed JC (1997). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
44. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, and Cote RJ (1998). Prognostic markers in bladder cancer: A contemporary review of the literature. J Urol 160:645-659.
45. Swana HS, Grossman D, Anthony JN, Weiss RM, and Altieri DC (1999). Antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453.
46. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, and Reed JC (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320.
47. Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S, and Otsu M (1998). AIM-1: A mammalian midbody-associated protein required for cytokinesis. EMBO J 17:667-676.
48. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
49. Uren AG, Coulson EJ, and Vaux DL (1998). Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biol Sci 23:159-162.
50. Uren AG, Pakusch M, Hawkins CJ, Puis KL, and Vaux DL (1996). Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93:4974-4978.
51. + individuals. Virology 206:196-202.
52. Vaux DL and Korsmeyer SJ (1999). Cell death in development. Cell 96:245-254.
53. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS Jr (1998). NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
54. Yang E and Korsmeyer SJ (1996). Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386-401.
55. Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, and Muller R (1995). Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 14:4514-4522.